These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1095963)

  • 21. [Metabolism pathways and use of heptral in chronic liver diseases].
    Il'chenko LIu; Vinnitskaia EV
    Eksp Klin Gastroenterol; 2002; (2):62-4, 103. PubMed ID: 12046390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A trial of using Geptral in patients with chronic liver diseases].
    Gorbakov VV; Kalinin AV; Ermolin SN
    Voen Med Zh; 1996 Dec; 317(12):29-31. PubMed ID: 9163214
    [No Abstract]   [Full Text] [Related]  

  • 23. [S-adenosylmethionine (SAM) in geriatric therapy].
    Jori E; Dallari A
    Minerva Med; 1973 Sep; 64(67):3485-91. PubMed ID: 4746873
    [No Abstract]   [Full Text] [Related]  

  • 24. [Quantitative immunological blood protein studies in liver diseases].
    Müller HE; Müller-von Voigt I
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Sep; 133(4):366-75. PubMed ID: 4173553
    [No Abstract]   [Full Text] [Related]  

  • 25. [Parenteral S-adenosylmethionine compared to placebos in the treatment of alcoholic liver diseases].
    Diaz Belmont A; Dominguez Henkel R; Uribe Ancira F
    An Med Interna; 1996 Jan; 13(1):9-15. PubMed ID: 8679834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacological and clinical aspects of S-adenosylmethionine (SAMe) in primary degenerative arthropathy (osteoarthrosis)].
    Polli E; Cortellaro M; Parrini L; Tessari L; Chériè Lignière G
    Minerva Med; 1975 Dec; 66(83):4443-59. PubMed ID: 1105240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Individual serum proteins in chronic liver diseases].
    Maleew A; Krustev Z; Kolarski W; Schipkov T
    Dtsch Z Verdau Stoffwechselkr; 1978; 38(3):95-9. PubMed ID: 679877
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of hepatic disease on the pharmacokinetics of famotidine and effects of famotidine on hepatic hemodynamics and peptic ulcer.
    Ohnishi K
    Hepatogastroenterology; 1990 Jul; 37 Suppl 1():6-10. PubMed ID: 2210613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical trial of coenzyme A in hepatopathies].
    Magaraci G
    Minerva Med; 1976 Feb; 67(8):512-8. PubMed ID: 943732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Heptral in treating chronic liver diseases].
    Minushkin ON
    Eksp Klin Gastroenterol; 2002; (1):75-7. PubMed ID: 12271591
    [No Abstract]   [Full Text] [Related]  

  • 32. What is SAMe? S-Adenosylmethionine.
    Cowley G; Underwood A
    Newsweek; 1999 Jul; 134(1):46-50. PubMed ID: 10538206
    [No Abstract]   [Full Text] [Related]  

  • 33. Mesenchymal reaction and serum glycoprotein concentration in chronic hepatitis and liver cirrhosis.
    Fehér J; Jakab L; Józsa L; Szilvási I; Papp G
    Acta Morphol Acad Sci Hung; 1975; 23(4):319-26. PubMed ID: 1234831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heptral potentialities in the treatment of hepatic damage in children with malignant blood disease].
    Reĭzis AR; Nurmukhametova EA
    Ter Arkh; 1998; 70(10):48-51. PubMed ID: 9864805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of the study of bile salts in acute and chronic liver disease].
    D'Aquino M; Della Sala S; Fazzin G; Michieletto L; Saonato F
    Quad Sclavo Diagn; 1987 Jun; 23(2):132-6. PubMed ID: 3451290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the studies on the clinical use of S-adenosylmethionine (SAMe) for the symptomatic treatment of intrahepatic cholestasis.
    Coltorti M; Bortolini M; Di Padova C
    Methods Find Exp Clin Pharmacol; 1990; 12(1):69-78. PubMed ID: 2179653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of methionine in liver disease.
    Mato JM; Ortiz P
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():35-46. PubMed ID: 8899692
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum levels of C3 and cholinesterase in various diseases of the liver.
    Jorge AD; Sanchez D
    Acta Hepatogastroenterol (Stuttg); 1976 Feb; 23(1):19-25. PubMed ID: 1258598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders.
    Gallo V; Cerutti E; Riberi A; Re M; Petrino R; Pecchio F
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):89-93. PubMed ID: 2480432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.